News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
AstraZeneca PLC Aims to Sell Nasal Flu Vaccine in EU
January 6, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Jan 6 (Reuters) - AstraZeneca hopes to sell a nasal spray flu vaccine that is already available in the United States in Europe as well.
Twitter
LinkedIn
Facebook
Email
Print
Europe
AstraZeneca
MORE ON THIS TOPIC
Huntington’s disease
UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel
April 30, 2026
·
2 min read
·
Heather McKenzie
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
April 22, 2026
·
2 min read
·
Tristan Manalac
Insights
Funding the future of European biotech
April 16, 2026
·
1 min read
·
Jennifer C. Smith-Parker
